IPO Watch: BioMimetic Therapeutics, Inc. Combines Drugs And Devices

May 17, 2006 – BioMimetic transcends the usual distinction between biotechs and device companies. It’s a little bit of both. The company concentrates on therapies for rebuilding parts of the skeleton and associated tissues, whether the problems are caused by injury or disease. The products from the company - one approved, the others in development - combine a synthetic dissolvable scaffold that supports regeneration of bone/tissue with a protein growth factor that stimulates regrowth. We look at the products and the company...

Back to news